Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
ANGLE PLC (GB:AGL)
LSE:AGL
ANGLE plc (AGL) Share Price & Analysis
25 Followers
AGL Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range9.05p - 37.34p
Previous Close14.75p
Volume1.17M
Average Volume (3M)2.05M
Market Cap
£47.57M
Enterprise Value20.68M
Total Cash (Recent Filing)£31.90M
Total Debt (Recent Filing)£5.00M
Price to Earnings (P/E)―
Beta1.77
Next Earnings
Sep 26, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.08
Shares Outstanding260,580,547
10 Day Avg. Volume2,099,199
30 Day Avg. Volume2,054,039
Standard Deviation0.19
R-Squared0.03
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)1.27
Price to Sales (P/S)33096.24
Price to Cash Flow (P/CF)-2.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
70.00pPrice Target Upside374.58% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
ANGLE plc News
PremiumCompany Announcements
ANGLE plc Announces Major Share Ownership Shift
PremiumCompany Announcements
ANGLE plc Triumphs at Annual General Meeting
PremiumCompany Announcements
ANGLE plc Secures £9.3m for Cancer Diagnostics Growth
PremiumCompany Announcements
ANGLE plc Circulates Annual Report and AGM Notice
PremiumCompany Announcements
ANGLE plc Innovates Cancer Diagnostics at EACR 2024
PremiumCompany Announcements
ANGLE plc Unveils Shareholder Open Offer Details
PremiumCompany Announcements
ANGLE plc Secures Funds to Boost Cancer Care
PremiumCompany Announcements
ANGLE plc Doubles Revenue and Expands Pharma PartnershipsOptions Prices
Currently, No data available
---
Ownership Overview
3.01%
Insiders
0.99% Mutual Funds
0.00% Other Institutional Investors
96.00% Public Companies and
Individual Investors
AGL FAQ
What was ANGLE PLC’s price range in the past 12 months?
ANGLE PLC lowest share price was 9.05p and its highest was 37.34p in the past 12 months.
What is ANGLE PLC’s market cap?
Currently, no data Available
When is ANGLE PLC’s upcoming earnings report date?
ANGLE PLC’s upcoming earnings report date is Sep 26, 2024 which is in 71 days.
How were ANGLE PLC’s earnings last quarter?
ANGLE PLC released its earnings results on Jun 05, 2024. The company reported -0.04p earnings per share for the quarter, missing the consensus estimate of N/A by -0.04p.
Is ANGLE PLC overvalued?
According to Wall Street analysts ANGLE PLC’s price is currently Undervalued.
Does ANGLE PLC pay dividends?
ANGLE PLC does not currently pay dividends.
What is ANGLE PLC’s EPS estimate?
ANGLE PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ANGLE PLC have?
ANGLE PLC has 322,641,660 shares outstanding.
What happened to ANGLE PLC’s price movement after its last earnings report?
ANGLE PLC reported an EPS of -0.04p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -13.856%.
Which hedge fund is a major shareholder of ANGLE PLC?
Currently, no hedge funds are holding shares in GB:AGL
---
ANGLE plc Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
70.00p (374.58% Upside)
70.00p (374.58% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
23.12%
12-Months-Change
Fundamentals
Return on Equity
-63.91%
Trailing 12-Months
Asset Growth
-37.47%
Trailing 12-Months
Company Description
ANGLE PLC
ANGLE PLC is active in the healthcare sector in the United Kingdom. It is a medical diagnostic company specializing in the development of pioneering products in cancer diagnostics. Its patented Parsortix technology has the potential to treat and diagnose the various forms of cancer. The Parsortix system can capture and harvest (Circulating Tumor Cells)CTCs from patient blood. Its geographical segments include Europe and North America, of which the majority of the revenue is generated from Europe.
---
AGL Stock 12 Month Forecast
Average Price Target
70.00p
▲(374.58% Upside)
Technical Analysis
Best Analysts Covering AGL
1 Year
1 Year Success Rate
2/11 ratings generated profit
1 Year Average Return
-43.27%
reiterated a buy rating 3 months ago
Copying Odysseas Manesiotis's trades and holding each position for 1 Year would result in 18.18% of your transactions generating a profit, with an average return of -43.27% per trade.
---